NR2F6 as a Prognostic Biomarker in HNSCC

Head and neck squamous cell carcinoma (HNSCC)is the 6th most common cancer in humans worldwide and is associated with a poor prognosis for patients. NR2F6 has been identified as an immune checkpoint molecule in tumor-infiltrating T lymphocytes and is associated with a poor prognostic outcome in vari...

Descripción completa

Detalles Bibliográficos
Autores principales: Klapper, Luise, Ribbat-Idel, Julika, Kuppler, Patrick, Paulsen, Finn-Ole, Bruchhage, Karl-Ludwig, Rades, Dirk, Offermann, Anne, Kirfel, Jutta, Wollenberg, Barbara, Idel, Christian, Perner, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432340/
https://www.ncbi.nlm.nih.gov/pubmed/32752295
http://dx.doi.org/10.3390/ijms21155527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432340/
https://www.ncbi.nlm.nih.gov/pubmed/32752295
http://dx.doi.org/10.3390/ijms21155527

Ejemplares similares